Didier Desmaele - Publications

Affiliations: 
1985-1987 Harvard University, Cambridge, MA, United States 

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ho DK, Murgia X, De Rossi C, Christmann R, G Hüfner de Mello Martins A, Koch M, Andreas A, Herrmann J, Müller R, Empting M, W Hartmann R, Desmaele D, Loretz B, Couvreru P, Lehr CM. Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and Alkylquinolone Quorum Sensing Inhibitor to Eradicate P. aeruginosa Biofilm Infections. Angewandte Chemie (International Ed. in English). PMID 32243047 DOI: 10.1002/Anie.202001407  0.34
2020 Peramo A, Abdellah I, Pecnard S, Mougin J, Martini C, Couvreur P, Huc V, Desmaële D. A Self-Assembling NHC-Pd-Loaded Calixarene as a Potent Catalyst for the Suzuki-Miyaura Cross-Coupling Reaction in Water. Molecules (Basel, Switzerland). 25. PMID 32213875 DOI: 10.3390/Molecules25061459  0.31
2020 Gobeaux F, Bizeau J, Samson F, Marichal L, Grillo I, Wien F, Yesylevsky SO, Ramseyer C, Rouquette M, Lepêtre-Mouelhi S, Desmaële D, Couvreur P, Guenoun P, Renault JP, Testard F. Albumin-driven disassembly of lipidic nanoparticles: the specific case of the squalene-adenosine nanodrug. Nanoscale. PMID 31961354 DOI: 10.1039/C9Nr06485K  0.378
2020 Li X, Porcel E, Menendez‐Miranda M, Qiu J, Yang X, Serre C, Pastor A, Desmaële D, Lacombe S, Gref R. Front Cover: Highly Porous Hybrid Metal–Organic Nanoparticles Loaded with Gemcitabine Monophosphate: a Multimodal Approach to Improve Chemo‐ and Radiotherapy (ChemMedChem 3/2020) Chemmedchem. 15: 263-263. DOI: 10.1002/Cmdc.202000030  0.331
2020 Ho D, Murgia X, Rossi CD, Christmann R, Martins AGHdM, Koch M, Andreas A, Herrmann J, Müller R, Empting M, Hartmann RW, Desmaele D, Loretz B, Couvreur P, Lehr C. Cover Picture: Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections (Angew. Chem. Int. Ed. 26/2020) Angewandte Chemie. 59: 10201-10201. DOI: 10.1002/Anie.202005838  0.324
2020 Ho D, Murgia X, Rossi CD, Christmann R, Martins AGHdM, Koch M, Andreas A, Herrmann J, Müller R, Empting M, Hartmann RW, Desmaele D, Loretz B, Couvreur P, Lehr C. Titelbild: Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections (Angew. Chem. 26/2020) Angewandte Chemie. 132: 10285-10285. DOI: 10.1002/Ange.202005838  0.326
2019 Peramo A, Dumas A, Remita H, Benoît M, Yen-Nicolay S, Corre R, Louzada RA, Dupuy C, Pecnard S, Lambert B, Young J, Desmaële D, Couvreur P. Selective modification of a native protein in a patient tissue homogenate using palladium nanoparticles. Chemical Communications (Cambridge, England). PMID 31782421 DOI: 10.1039/C9Cc07803G  0.322
2019 Li X, Serre C, Porcel E, Menendez-Miranda M, Qiu J, Yang X, Pastor A, Desmaële D, Lacombe S, Gref R. Highly porous hybrid metal-organic nanoparticles loaded with gemcitabine-monophosphate: a multimodal approach to improve chemo and radiotherapy. Chemmedchem. PMID 31765517 DOI: 10.1002/Cmdc.201900596  0.337
2019 Rodríguez-Nogales C, Sebastián V, Irusta S, Desmaële D, Couvreur P, Blanco-Prieto MJ. A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine. European Journal of Pharmaceutics and Biopharmaceutics. 144: 165-173. PMID 31546021 DOI: 10.1016/J.Ejpb.2019.09.017  0.362
2019 Cutrone G, Qiu J, Menendez-Miranda M, Casas-Solvas JM, Aykaç A, Li X, Foulkes D, Moreira-Alvarez B, Encinar JR, Ladavière C, Desmaële D, Vargas-Berenguel A, Gref R. Comb-like dextran copolymers: A versatile strategy to coat highly porous MOF nanoparticles with a PEG shell. Carbohydrate Polymers. 223: 115085. PMID 31426973 DOI: 10.1016/J.Carbpol.2019.115085  0.353
2019 Dormont F, Rouquette M, Mahatsekake C, Gobeaux F, Peramo A, Brusini R, Calet S, Testard F, Lepetre-Mouelhi S, Desmaële D, Varna M, Couvreur P. Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31260754 DOI: 10.1016/J.Jconrel.2019.06.040  0.379
2019 Pastor A, Machelart A, Li X, Willand N, Baulard A, Brodin P, Gref R, Desmaële D. A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation. Organic & Biomolecular Chemistry. 17: 5129-5137. PMID 31073555 DOI: 10.1039/C9Ob00680J  0.42
2018 Pancani E, Menendez-Miranda M, Pastor A, Brisset F, Bernet-Camard MF, Desmaële D, Gref R. Nanoparticles with high payloads of pipemidic acid, a poorly soluble crystalline drug: drug-initiated polymerization and self-assembly approach. Acta Pharmaceutica Sinica. B. 8: 420-431. PMID 29881681 DOI: 10.1016/J.Apsb.2018.03.008  0.375
2018 Massaad-Massade L, Boutary S, Caillaud M, Gracia C, Parola B, Bel Gnaouiya S, Stella B, Arpicco S, Buchy E, Desmaêle D, Couvreur P, Urbinati G. A new formulation for the delivery of oligonucleotides using "clickable" siRNA-polyisoprenoid-conjugated nanoparticles: application to cancers harboring fusion oncogenes. Bioconjugate Chemistry. PMID 29727181 DOI: 10.1021/Acs.Bioconjchem.8B00205  0.399
2017 Cayre F, Mura S, Andreiuk B, Sobot D, Gouazou S, Desmaële D, Klymchenko AS, Couvreur P. In Vivo FRET Imaging to Predict the Risk Associated with Hepatic Accumulation of Squalene-Based Prodrug Nanoparticles. Advanced Healthcare Materials. PMID 29195020 DOI: 10.1002/Adhm.201700830  0.336
2017 Sobot D, Mura S, Rouquette M, Vukosavljevic B, Cayre F, Buchy E, Pieters G, Garcia-Argote S, Windbergs M, Desmaële D, Couvreur P. Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28606375 DOI: 10.1016/J.Ymthe.2017.05.016  0.34
2017 Sobot D, Mura S, Yesylevskyy SO, Dalbin L, Cayre F, Bort G, Mougin J, Desmaële D, Lepetre-Mouelhi S, Pieters G, Andreiuk B, Klymchenko AS, Paul JL, Ramseyer C, Couvreur P. Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery. Nature Communications. 8: 15678. PMID 28555624 DOI: 10.1038/Ncomms15678  0.332
2017 Skarbek C, Delahousse J, Pioche-Durieu C, Baconnais S, Deroussent A, Renevret P, Rivard M, Desmaele D, Martens T, Le Cam E, Couvreur P, Paci A. Poly-isoprenylated ifosfamide analogs: Preactivated antitumor agents as free formulation or nanoassemblies. International Journal of Pharmaceutics. PMID 28546071 DOI: 10.1016/J.Ijpharm.2017.05.044  0.336
2017 Kotelevets L, Chastre E, Caron J, Mougin J, Bastian G, Pineau A, Walker F, Lehy T, Desmaele D, Couvreur P. A squalene-based nanomedicine for oral treatment of colon cancer. Cancer Research. PMID 28416486 DOI: 10.1158/0008-5472.Can-16-1741  0.342
2017 Gaudin A, Song E, Amanda K, Desmaele D, Couvreur P, Saltzman M. Abstract B33: PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B33  0.375
2016 Kotelevets L, Chastre E, Desmaële D, Couvreur P. Nanotechnologies for the treatment of colon cancer: From old drugs to new hope. International Journal of Pharmaceutics. 514: 24-40. PMID 27863668 DOI: 10.1016/J.Ijpharm.2016.06.005  0.313
2016 Buchy E, Vukosavljevic B, Windbergs M, Sobot D, Dejean C, Mura S, Couvreur P, Desmaële D. Synthesis of a deuterated probe for the confocal Raman microscopy imaging of squalenoyl nanomedicines. Beilstein Journal of Organic Chemistry. 12: 1127-35. PMID 27559365 DOI: 10.3762/Bjoc.12.109  0.349
2016 Mura S, Buchy E, Askin G, Cayre F, Mougin J, Gouazou S, Sobot D, Valetti S, Stella B, Desmaele D, Couvreur P. In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better. Biochimie. PMID 27519301 DOI: 10.1016/J.Biochi.2016.08.003  0.379
2016 Dumas A, Peramo A, Desmaële D, Couvreur P. PLGA-PEG-supported Pd Nanoparticles as Efficient Catalysts for Suzuki-Miyaura Coupling Reactions in Water. Chimia. 70: 252-7. PMID 27131109 DOI: 10.2533/Chimia.2016.252  0.361
2016 Urbinati G, de Waziers I, Slamiç M, Foussignière T, Ali HM, Desmaële D, Couvreur P, Massaad-Massade L. Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide. Molecular Therapy. Nucleic Acids. 5: e301. PMID 27023109 DOI: 10.1038/Mtna.2016.16  0.331
2016 Bao Y, Boissenot T, Guégain E, Desmaële D, Mura S, Couvreur P, Nicolas J. Simple Synthesis of Cladribine-Based Anticancer Polymer Prodrug Nanoparticles with Tunable Drug Delivery Properties Chemistry of Materials. 28: 6266-6275. DOI: 10.1021/Acs.Chemmater.6B02502  0.343
2015 Lepeltier E, Loretz B, Desmaêle D, Zapp J, Herrmann J, Couvreur P, Lehr CM. Squalenoylation of Chitosan: a Platform for Drug-Delivery? Biomacromolecules. PMID 26221873 DOI: 10.1021/Acs.Biomac.5B00840  0.42
2015 Lepeltier E, Bourgaux C, Amenitsch H, Rosilio V, Lepetre-Mouelhi S, Zouhiri F, Desmaële D, Couvreur P. Influence of the nanoprecipitation conditions on the supramolecular structure of squalenoyled nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 26210010 DOI: 10.1016/J.Ejpb.2015.07.004  0.348
2015 Collery P, Mohsen A, Kermagoret A, Corre S, Bastian G, Tomas A, Wei M, Santoni F, Guerra N, Desmaële D, d'Angelo J. Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer. Investigational New Drugs. 33: 848-60. PMID 26108551 DOI: 10.1007/S10637-015-0265-Z  0.308
2015 Urbinati G, Ali HM, Rousseau Q, Chapuis H, Desmaële D, Couvreur P, Massaad-Massade L. Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer. Plos One. 10: e0125277. PMID 25933120 DOI: 10.1371/Journal.Pone.0125277  0.323
2015 Saha D, Testard F, Grillo I, Zouhiri F, Desmaele D, Radulescu A, Desert S, Brulet A, Couvreur P, Spalla O. The role of solvent swelling in the self-assembly of squalene based nanomedicines. Soft Matter. 11: 4173-9. PMID 25873336 DOI: 10.1039/C5Sm00592B  0.34
2015 Cheikh-Ali Z, Caron J, Cojean S, Bories C, Couvreur P, Loiseau PM, Desmaële D, Poupon E, Champy P. "Squalenoylcurcumin" nanoassemblies as water-dispersible drug candidates with antileishmanial activity. Chemmedchem. 10: 411-8. PMID 25523035 DOI: 10.1002/Cmdc.201402449  0.327
2015 de Miguel L, Popa I, Noiray M, Caudron E, Arpinati L, Desmaele D, Cebrián-Torrejón G, Doménech-Carbó A, Ponchel G. Osteotropic polypeptide nanoparticles with dual hydroxyapatite binding properties and controlled cisplatin delivery. Pharmaceutical Research. 32: 1794-803. PMID 25504453 DOI: 10.1007/S11095-014-1576-Z  0.305
2015 Skarbek C, Lesueur LL, Chapuis H, Deroussent A, Pioche Durieu C, Daville A, Caron J, Rivard M, Martens T, Bertrand JR, Le Cam E, Vassal G, Couvreur P, Desmaele D, Paci A. Preactivated oxazaphosphorines designed for isophosphoramide mustard delivery as bulk form or nanoassemblies: synthesis and proof of concept. Journal of Medicinal Chemistry. 58: 705-17. PMID 25494842 DOI: 10.1021/Jm501224X  0.373
2015 Gaudin A, Tagit O, Sobot D, Lepetre-Mouelhi S, Mougin J, Martens TF, Braeckmans K, Nicolas V, Desmaële D, Smedt SCd, Hildebrandt N, Couvreur P, Andrieux K. Transport Mechanisms of Squalenoyl-Adenosine Nanoparticles Across the Blood–Brain Barrier Chemistry of Materials. 27: 3636-3647. DOI: 10.1021/Acs.Chemmater.5B00267  0.309
2015 Buchy E, Valetti S, Mura S, Mougin J, Troufflard C, Couvreur P, Desmaële D. Synthesis and Cytotoxic Activity of Self‐Assembling Squalene Conjugates of 3‐[(Pyrrol‐2‐yl)methylidene]‐2,3‐dihydro‐1H‐indol‐2‐one Anticancer Agents European Journal of Organic Chemistry. 2015: 202-212. DOI: 10.1002/Ejoc.201403088  0.348
2014 Valetti S, Mura S, Noiray M, Arpicco S, Dosio F, Vergnaud J, Desmaële D, Stella B, Couvreur P. Peptide conjugation: before or after nanoparticle formation? Bioconjugate Chemistry. 25: 1971-83. PMID 25313527 DOI: 10.1021/Bc5003423  0.331
2014 Lepeltier E, Bourgaux C, Maksimenko A, Meneau F, Rosilio V, Sliwinski E, Zouhiri F, Desmaële D, Couvreur P. Self-assembly of polyisoprenoyl gemcitabine conjugates: influence of supramolecular organization on their biological activity. Langmuir : the Acs Journal of Surfaces and Colloids. 30: 6348-57. PMID 24835925 DOI: 10.1021/La5007132  0.75
2014 Maksimenko A, Alami M, Zouhiri F, Brion JD, Pruvost A, Mougin J, Hamze A, Boissenot T, Provot O, Desmaële D, Couvreur P. Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy. Acs Nano. 8: 2018-32. PMID 24555414 DOI: 10.1021/Nn500517A  0.401
2014 Ali HM, Maksimenko A, Urbinati G, Chapuis H, Raouane M, Desmaële D, Yasuhiro H, Harashima H, Couvreur P, Massaad-Massade L. Effects of silencing the RET/PTC1 oncogene in papillary thyroid carcinoma by siRNA-squalene nanoparticles with and without fusogenic companion GALA-cholesterol. Thyroid : Official Journal of the American Thyroid Association. 24: 327-38. PMID 23885719 DOI: 10.1089/Thy.2012.0544  0.33
2014 Caron J, Maksimenko A, Mougin J, Couvreur P, Desmaële D. Combined antitumoral therapy with nanoassemblies of bolaform polyisoprenoyl paclitaxel/gemcitabine prodrugs Polymer Chemistry. 5: 1662-1673. DOI: 10.1039/C3Py01177A  0.387
2014 Maksimenko A, Bui DT, Desmaële D, Couvreur P, Nicolas J. Significant tumor growth inhibition from naturally occurring lipid-containing polymer prodrug nanoparticles obtained by the drug-initiated method Chemistry of Materials. 26: 3606-3609. DOI: 10.1021/Cm501500K  0.339
2013 Lepeltier E, Bourgaux C, Rosilio V, Poupaert JH, Meneau F, Zouhiri F, Lepêtre-Mouelhi S, Desmaële D, Couvreur P. Self-assembly of squalene-based nucleolipids: relating the chemical structure of the bioconjugates to the architecture of the nanoparticles. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 14795-803. PMID 24219056 DOI: 10.1021/La403338Y  0.377
2013 Mura S, Zouhiri F, Lerondel S, Maksimenko A, Mougin J, Gueutin C, Brambilla D, Caron J, Sliwinski E, Lepape A, Desmaele D, Couvreur P. Novel isoprenoyl nanoassembled prodrug for paclitaxel delivery. Bioconjugate Chemistry. 24: 1840-9. PMID 24134705 DOI: 10.1021/Bc400210X  0.752
2013 Maksimenko A, Mougin J, Mura S, Sliwinski E, Lepeltier E, Bourgaux C, Lepêtre S, Zouhiri F, Desmaële D, Couvreur P. Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy. Cancer Letters. 334: 346-53. PMID 22935679 DOI: 10.1016/j.canlet.2012.08.023  0.739
2012 Raouane M, Desmaële D, Urbinati G, Massaad-Massade L, Couvreur P. Lipid conjugated oligonucleotides: a useful strategy for delivery. Bioconjugate Chemistry. 23: 1091-104. PMID 22372953 DOI: 10.1021/Bc200422W  0.309
2012 Desmaële D, Gref R, Couvreur P. Squalenoylation: a generic platform for nanoparticular drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 161: 609-18. PMID 21840355 DOI: 10.1016/J.Jconrel.2011.07.038  0.356
2011 Raouane M, Desmaele D, Gilbert-Sirieix M, Gueutin C, Zouhiri F, Bourgaux C, Lepeltier E, Gref R, Ben Salah R, Clayman G, Massaad-Massade L, Couvreur P. Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma. Journal of Medicinal Chemistry. 54: 4067-76. PMID 21561161 DOI: 10.1021/Jm2000272  0.357
2011 Caron J, Lepeltier E, Reddy LH, Lepêtre‐Mouelhi S, Wack S, Bourgaux C, Couvreur P, Desmaële D. Squalenoyl Gemcitabine Monophosphate: Synthesis, Characterisation of Nanoassemblies and Biological Evaluation (Eur. J. Org. Chem. 14/2011) European Journal of Organic Chemistry. 2011. DOI: 10.1002/Ejoc.201190033  0.398
2011 Caron J, Lepeltier E, Reddy LH, Lepêtre‐Mouelhi S, Wack S, Bourgaux C, Couvreur P, Desmaële D. Squalenoyl Gemcitabine Monophosphate: Synthesis, Characterisation of Nanoassemblies and Biological Evaluation European Journal of Organic Chemistry. 2011: 2615-2628. DOI: 10.1002/Ejoc.201100036  0.348
2009 Bildstein L, Hillaireau H, Desmaële D, Lepêtre-Mouelhi S, Dubernet C, Couvreur P. Freeze-drying of squalenoylated nucleoside analogue nanoparticles. International Journal of Pharmaceutics. 381: 140-5. PMID 19782881 DOI: 10.1016/J.Ijpharm.2009.04.002  0.35
2007 Kim HR, Andrieux K, Delomenie C, Chacun H, Appel M, Desmaële D, Taran F, Georgin D, Couvreur P, Taverna M. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system. Electrophoresis. 28: 2252-61. PMID 17557357 DOI: 10.1002/Elps.200600694  0.322
2007 Kim HR, Andrieux K, Gil S, Taverna M, Chacun H, Desmaële D, Taran F, Georgin D, Couvreur P. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. Biomacromolecules. 8: 793-9. PMID 17309294 DOI: 10.1021/Bm060711A  0.358
2007 Danet M, Morgant G, Tomas A, Desmaële D. Synthetic study toward 17-thiasteroids: synthesis of the 1-thiahydrinden-5-one subunit using a new annulation procedure and investigation of its reduction Tetrahedron. 63: 7172-7177. DOI: 10.1016/J.Tet.2007.04.093  0.301
2006 Drège E, Tominiaux C, Morgant G, Desmaële D. Synthetic Studies on Cyathin Terpenoids: Enantioselective Synthesis of the Tricyclic Core of Cyathin through Intramolecular Heck Cyclisation European Journal of Organic Chemistry. 2006: 4825-4840. DOI: 10.1002/Ejoc.200600429  0.33
2001 Calvo P, Gouritin B, Chacun H, Desmaële D, D'Angelo J, Noel JP, Georgin D, Fattal E, Andreux JP, Couvreur P. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharmaceutical Research. 18: 1157-66. PMID 11587488 DOI: 10.1023/A:1010931127745  0.336
2000 Brigger I, Chaminade P, Desmaële D, Peracchia MT, d'Angelo J, Gurny R, Renoir M, Couvreur P. Near infrared with principal component analysis as a novel analytical approach for nanoparticle technology. Pharmaceutical Research. 17: 1124-32. PMID 11087046 DOI: 10.1023/A:1026465931525  0.352
1999 Peracchia MT, Harnisch S, Pinto-Alphandary H, Gulik A, Dedieu JC, Desmaële D, d'Angelo J, Müller RH, Couvreur P. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials. 20: 1269-75. PMID 10403044 DOI: 10.1016/S0142-9612(99)00021-6  0.345
1999 Provot O, Camuzat-Dedenis B, Hamzaoui M, Moskowitz H, Mayrargue J, Robert A, Cazelles J, Meunier B, Zouhiri F, Desmaële D, d'Angelo J, Mahuteau J, Cicéron L. Structure–Activity Relationships of Synthetic Tricyclic Trioxanes Related to Artemisinin: The Unexpected Alkylative Property of a 3-(Methoxymethyl) Analog European Journal of Organic Chemistry. 1999: 1935-1938. DOI: 10.1002/(Sici)1099-0690(199908)1999:8<1935::Aid-Ejoc1935>3.0.Co;2-Y  0.329
1998 Peracchia MT, Vauthier C, Desmaële D, Gulik A, Dedieu JC, Demoy M, d'Angelo J, Couvreur P. Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharmaceutical Research. 15: 550-6. PMID 9587950 DOI: 10.1023/A:1011973625803  0.37
1998 Wimmer Z, Šaman D, Kuldová J, Desmaële D, d'Angelo J, Goudey-Perrière F. TheMichael-Type Addition Reaction: A Stereocontrolled Construction of a New Quaternary Chiral Center at C(2) of 2-(4-Hydroxybenzyl)cyclohexanone Derivatives Helvetica Chimica Acta. 81: 2017-2023. DOI: 10.1002/(Sici)1522-2675(19981111)81:11<2017::Aid-Hlca2017>3.0.Co;2-P  0.308
1997 Peracchia MT, Desmaële D, Couvreur P, D'Angelo J. Synthesis of a Novel Poly(MePEG cyanoacrylate-co-alkyl cyanoacrylate) Amphiphilic Copolymer for Nanoparticle Technology‡ Macromolecules. 30: 846-851. DOI: 10.1021/Ma961453K  0.382
1992 Desmaële D, Pain G, d'Angelo J. Asymmetric synthesis of trans-fused octahydro pyrano-pyran subunits related to marine polyether toxins Tetrahedron-Asymmetry. 3: 867-870. DOI: 10.1016/S0957-4166(00)82186-2  0.3
1992 Desmaële D. New approach to chiral 5,5-disubstituted tetronic acids. Enantioselective synthesis of (−)-vertinolide. Tetrahedron. 48: 2925-2934. DOI: 10.1016/S0040-4020(01)90974-3  0.3
1988 Schreiber SL, Desmaele D, Porco JA. On the use of unsymmetrically substituted furans in the furan-carbonyl photocycloaddition reaction: Synthesis of a kadsurenone-ginkgolide hybrid Tetrahedron Letters. 29: 6689-6692. DOI: 10.1016/S0040-4039(00)82429-6  0.562
1983 Desmaële D, Ficini J, Guingant A, Touzin A. Synthese totale et stereoselective du p.tolylsulfonylmethyl-8 des-ab-cholestene-8 Tetrahedron Letters. 24: 3083-3086. DOI: 10.1016/S0040-4039(00)88101-0  0.66
1983 Desmaële D, Ficini J, Guingant A, Kahn P. Influence de la substitution en 1 sur la stereoselectivite de l'hydrolyse de N,N diethylamino-7 dialkyl-1,6 bicyclo (3,2,0) heptene-6 ones-2 ; une nouvelle voie d'acces au controle des centres C17 et C20 de steroides Tetrahedron Letters. 24: 3079-3082. DOI: 10.1016/S0040-4039(00)88100-9  0.649
1983 DESMAELE D, FICINI J, GUINGANT A, TOUZIN AM. ChemInform Abstract: TOTAL STEREOSELECTIVE SYNTHESIS OF 8-P-TOLYLSULFONYLMETHYL-DES-AB-CHOLEST-8-ENE Chemischer Informationsdienst. 14. DOI: 10.1002/Chin.198345325  0.662
1983 DESMAELE D, FICINI J, GUINGANT A, KAHN P. ChemInform Abstract: EFFECT OF SUBSTITUTION AT THE 1 POSITION ON THE STEREOSELECTIVITY OF THE HYDROLYSIS OF N,N-DIETHYL-7-AMINO-1,6-DIALKYLBICYCLO(3.2.0)HEPT-6-EN-2-ONES; A NEW PATH FOR ACCESS TO THE CONTROL OF STEROIDAL C17 AND C20 CENTERS Chemischer Informationsdienst. 14. DOI: 10.1002/Chin.198345149  0.659
1981 Ficini J, Krief A, Guingant A, Desmaele D. Influence of magnesium bromide on the regioselectivity of the cycloaddition of ynamines with cyclenones: difference in reactivity between cyclohexenones and cyclopentenones Tetrahedron Letters. 22: 725-728. DOI: 10.1016/0040-4039(81)80134-7  0.635
Show low-probability matches.